|
|
Showing 1 - 2 of
2 matches in All Departments
Toby K. Eisenstein Symposium Committee Chairperson Temple
University School of Medicine Philadelphia, Pennsylvania 19140 This
symposium is the thirteenth biennial clinical microbiology program
sponsored by the Eastern Pennsylvania Branch of the American
Society for Microbiology in cooperation with the Philadelphia area
medical schools and the Bureau of Laboratories of the Pennsylvania
Department of Health. This year a generous contribution from Merck,
Sharp and Dohme has helped to make the program a reality. The
subject matter for this symposium represents an attractive spectrum
of medical, biological and molecular approaches to the practical
solution of a public health prob1em--name1y, prevention of
infection with the hepatitis B virus. The symposium may be unique
in that it focuses on a product which was first marketed less than
three months ago, but included in the program are presen tations on
two new approaches to hepatitis B vaccine production which may
replace the one which is newly unveiled. The rapidity of progress
in our present era of biological research is indeed astonishing."
Toby K. Eisenstein Symposium Committee Chairperson Temple
University School of Medicine Philadelphia, Pennsylvania 19140 This
symposium is the thirteenth biennial clinical microbiology program
sponsored by the Eastern Pennsylvania Branch of the American
Society for Microbiology in cooperation with the Philadelphia area
medical schools and the Bureau of Laboratories of the Pennsylvania
Department of Health. This year a generous contribution from Merck,
Sharp and Dohme has helped to make the program a reality. The
subject matter for this symposium represents an attractive spectrum
of medical, biological and molecular approaches to the practical
solution of a public health prob1em--name1y, prevention of
infection with the hepatitis B virus. The symposium may be unique
in that it focuses on a product which was first marketed less than
three months ago, but included in the program are presen tations on
two new approaches to hepatitis B vaccine production which may
replace the one which is newly unveiled. The rapidity of progress
in our present era of biological research is indeed astonishing."
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.